GSK announced that it is recalling the popular heartburn medication Zantac® in all markets worldwide.
The recall was quickly announced after the FDA reported finding “unacceptable” levels of a carcinogenic impurity called NDMA in the pills.
The recall involves prescription-only Zantac® medicines, including a syrup, an injection, and pills of 150 and 300 milligram (mg) dosages.
Over-the-counter 75-mg doses of brand-name Zantac® are made by a different drug-maker and are not included in the recall.
Several recalls have been issued for generic Zantac (ranitidine) and over-the-counter products that include ranitidine.
Novartis halted distribution of ranitidine last month. Walmart, Walgreens, CVS, and Rite Aid have also suspended sales of over-the-counter heartburn drugs containing ranitidine.